Skip to main content
Monday, November 16, 2026Nov 16

Pfizer seeks to expand omicron booster to 5- to 11-year-olds

FILE - A Jackson, Miss., resident receives a Pfizer booster shot from a nurse at a vaccination site Feb. 8, 2022. Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11, Monday, Sept. 26. Already 4.4 million Americans have received one of the updated boosters since they rolled out earlier this month for anyone 12 and older. (AP Photo/Rogelio V. Solis, File)
FILE - A Jackson, Miss., resident receives a Pfizer booster shot from a nurse at a vaccination site Feb. 8, 2022. Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11, Monday, Sept. 26. Already 4.4 million Americans have received one of the updated boosters since they rolled out earlier this month for anyone 12 and older. (AP Photo/Rogelio V. Solis, File)

Pfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11.

Elementary school-aged children already received kid-sized doses of Pfizer’s original vaccine, a third of the dose given to everyone 12 and older — two primary shots plus a booster.

If the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it is time for their booster.

FDA vaccine chief Dr. Peter Marks said last week he expected a decision on boosters for that age group soon.

Pfizer and its partner BioNTech also announced a new study of the omicron-focused booster in even younger children, those ages 6 months through 4 years, to test different doses.